Variation in the availability of cancer drug generics in the United States of America.

Variation in the availability of cancer drug generics in the United States of America.

While most of the attention and spending in the oncology community in the United States has been focused on the remarkable scientific inventions of the newer targeted drugs, the shortage of the older essential cancer drugs that are off patent, mostly generics and injectables, has a threatening impac...

Полное описание

Библиографические подробности
Главные авторы:	Elzawawy, A, Kerr, D
Формат:	Journal article
Язык:	English
Опубликовано:	2013

Схожие документы

Generic drugs: their role in better value cancer care.
по: Kerr, D
Опубликовано: (2013)

Evaluation of Patient Assistance Program Eligibility and Availability for Top 200 Brand Name and Generic Drugs in the United States
по: Chin-Fun Chu, и др.
Опубликовано: (2012-01-01)

Paying physicians to prescribe generic drugs and follow-on biologics in the United States.
по: Ameet Sarpatwari, и др.
Опубликовано: (2015-03-01)

Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa?
по: Varsha Bangalee, и др.
Опубликовано: (2016-10-01)

Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa?
по: Varsha Bangalee, и др.
Опубликовано: (2016-12-01)

Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available
по: F. V. Gorkavenko, и др.
Опубликовано: (2019-07-01)

The Quality of Generic Drugs Available in Hospital Drugs List: A Case Study of Songklanagarind Hospital
по: Dusit Supawatanawong
Опубликовано: (2014-06-01)

Targeted therapies: Manufacturer sponsorship bias in economic analyses matters.
по: Kerr, D, и др.
Опубликовано: (2012)

Targeted therapies: Manufacturer sponsorship bias in economic analyses matters
по: Kerr, D, и др.
Опубликовано: (2012)

Risk Assessment of Failures in Generic Drug Development and Approval Procedure under Competitive Generic Drug Therapy and Patent Challenge Exclusivities Provided by the United States Food and Drug Administration
по: Reddy M Vivek, и др.
Опубликовано: (2022-03-01)

Availability of Injectable Antimicrobial Drugs for Gonorrhea and Syphilis, United States, 2016
по: William S. Pearson, и др.
Опубликовано: (2019-11-01)

Availability and Affordability of Oncology Drugs in 2012-2021 in China and the United States
по: Huiyao Huang, и др.
Опубликовано: (2022-07-01)

Variation of Cost among Anti-cancer Drugs Available in Indian Market
по: Bhanu Prakash Kolasani, и др.
Опубликовано: (2016-11-01)

United States of America
по: Bobbi A. Kerlin
Опубликовано: (2000-01-01)

Universal Healthcare in the United States of America: A Healthy Debate
по: Gabriel Zieff, и др.
Опубликовано: (2020-10-01)

Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available.
по: Matthias Samwald, и др.
Опубликовано: (2016-01-01)

The effect of generic market entry on antibiotic prescriptions in the United States
по: Cecilia Kållberg, и др.
Опубликовано: (2021-05-01)

Variation in adverse drug events of opioids in the United States
по: Edward Y. Liu, и др.
Опубликовано: (2023-03-01)

Mathematics test available in the United States/
по: 236909 Myers, Sheldon S., и др.
Опубликовано: (1972)

Persistent geographic variations in availability and quality of nursing home care in the United States: 1996 to 2016
по: Yun Wang, и др.
Опубликовано: (2019-04-01)

The concept of: Generic drugs and patented drugs Vs brand name drugs and non-proprietary (generic) name drugs.
по: Karan eThakkar, и др.
Опубликовано: (2013-09-01)

Generic drugs for public health in India:………unbranded versus branded generics
по: M M Nagargoje, и др.
Опубликовано: (2017-01-01)

Mapping COVID vulnerability in relation to drug and alcohol recovery residence availability across the United States
по: Amy A. Mericle, и др.
Опубликовано: (2023-11-01)

Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs
по: Muhammad M. Hammami, и др.
Опубликовано: (2017-12-01)

Generic Substitutions for Antiepileptic Drugs
по: J Gordon Millichap
Опубликовано: (1990-11-01)

Generic Drugs or Branded Generics, Which One You Prefer to Prescribe?
по: Manjunath Premanath, и др.
Опубликовано: (2024-03-01)

Widespread Availability of Artemisinin Monotherapy in the United States
по: Robert M. Rakita, и др.
Опубликовано: (2011-05-01)

The availability of pharmacies in the United States: 2007-2015.
по: Dima Mazen Qato, и др.
Опубликовано: (2017-01-01)

Generic drugs: benefit/risk ratio
по: E. A. Ushkalova, и др.
Опубликовано: (2021-12-01)

The epidemiological trends of biliary tract cancers in the United States of America
по: Yong Jiang, и др.
Опубликовано: (2022-12-01)

The "Win-Win" initiative: a global, scientifically based approach to resource sparing treatment for systemic breast cancer therapy
по: Elzawawy Ahmed
Опубликовано: (2009-05-01)

Promoting generic drug usage in Japan: correlation between generic drug usage and monthly personal income
по: Takaaki Suzuki, и др.
Опубликовано: (2023-02-01)

Determinants of delayed detection of cancers in Texas Counties in the United States of America
по: Gong Gordon, и др.
Опубликовано: (2012-05-01)

NON-BIOLOGICAL COMPLEX DRUGS CONCEPT IN GENERIC DRUGS DEVELOPMENT
по: D. V. Goryachev, и др.
Опубликовано: (2018-03-01)

The United States of America and scientific research.
по: Gregory J Hather, и др.
Опубликовано: (2010-08-01)

More research is needed for generic drugs
по: Silvio Garattini
Опубликовано: (2012-10-01)

Generic drugs: myths, facts, and limitations
по: Antonio Marzo, и др.
Опубликовано: (2012-10-01)

More vigilance on generic drugs are necessary
по: Mathew John
Опубликовано: (2020-01-01)

New prices for generic equivalent drugs
по: Ombretta Bandi
Опубликовано: (2011-11-01)

Determinants of generic drug substitution in Switzerland
по: Lufkin Thomas M, и др.
Опубликовано: (2011-01-01)